BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6306636)

  • 41. [Treatment of microcytic carcinoma of the lung with vincristine, adriamycin, cyclophosphamide and VP-16].
    Sangro Gómez-Acebo B; Díaz-Rubio García E; Martín Jiménez M; González Larriba JL; Vila Borrajo C
    Rev Clin Esp; 1986 Oct; 179(6):296-301. PubMed ID: 3025943
    [No Abstract]   [Full Text] [Related]  

  • 42. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
    Elisson LO; Ekberg L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):15-7. PubMed ID: 7846536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Ettinger DS
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of small cell lung carcinoma associated with pneumoconiosis who responded well to the over twenty chemotherapy treatments, resulting in prolonged survival].
    Sassa K; Mizushima Y; Yoshida Y; Shinoda K; Kobayashi M
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):609-12. PubMed ID: 9087297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Randomized systemic chemotherapy using two or three drug combination for small cell lung cancer (SCLC)].
    Eguchi K; Shimizu E; Shinkai T; Tominaga K; Saijo N; Shimabukuro Z; Shibuya M; Niitani H
    Gan No Rinsho; 1984 Feb; 30(2):115-21. PubMed ID: 6323783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of small cell lung cancer in elderly.
    Satoh H; Ishikawa H; Funayama Y; Yamashita YT; Kamma H; Ohtsuka M; Sekizawa K
    Anticancer Res; 1999; 19(5C):4507-10. PubMed ID: 10650801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Polychemotherapy in inoperable bronchial carcinoma].
    Schmidt CG
    Strahlentherapie; 1984 Feb; 160(2):71-6. PubMed ID: 6328699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
    Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
    Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of polychemotherapy in bronchial cancer].
    Sroczyński J; Wegiel A; Nałogowska K
    Wiad Lek; 1984 Apr; 37(8):589-93. PubMed ID: 6093390
    [No Abstract]   [Full Text] [Related]  

  • 50. Histologic alterations in small cell carcinoma of the lung after two cycles of intensive chemotherapy.
    Meyer JA; Ikins PM; Gullo JJ; Comis RL; Burke WA; DiFino SM; Parker FB
    J Thorac Cardiovasc Surg; 1984 Feb; 87(2):283-90. PubMed ID: 6319829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial chemotherapeutic doses and long-term survival in limited small-cell lung cancer.
    Arriagada R; Pignon JP; Le Chevalier T
    N Engl J Med; 2001 Oct; 345(17):1281-2. PubMed ID: 11680466
    [No Abstract]   [Full Text] [Related]  

  • 52. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 54. [Combination treatment of small cell bronchial carcinoma].
    Voss AC; Steinke B; Ostendorf P; Teller P; Gnann H
    Strahlentherapie; 1983 Jan; 159(1):18-21. PubMed ID: 6301108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
    Dangubić V; Vukov N; Mrda V; Spasić D; Sikimić S; Popvić D; Perunović O; Bjelić R
    Zb Vojnomed Akad; 1983; 25():40-4. PubMed ID: 6099941
    [No Abstract]   [Full Text] [Related]  

  • 56. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
    Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
    Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
    [No Abstract]   [Full Text] [Related]  

  • 57. Eaton-Lambert syndrome as a harbinger of recurrent small-cell carcinoma of the cervix with improvement after combination chemotherapy.
    Sutton GP; Siemers E; Stehman FB; Ehrlich CE
    Obstet Gynecol; 1988 Sep; 72(3 Pt 2):516-8. PubMed ID: 2841632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the effectiveness of 2-drug and multi-drug chemotherapy in primary lung cancer].
    Durda M; Skublewski A; Patyra R; Ziemecka E
    Pneumonol Pol; 1979; 47(7-8):603-7. PubMed ID: 231773
    [No Abstract]   [Full Text] [Related]  

  • 59. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
    Livingston RB; Mira J; O'Bryan RM
    Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
    [No Abstract]   [Full Text] [Related]  

  • 60. Small cell cancer of lung; rapid tumor necrosis leading to serious pulmonary infections after intensive chemotherapy.
    Brandman JR; Ruckdeschel JC; O'Donnell MR; Horton J
    N Y State J Med; 1981 Aug; 81(9):1332-4. PubMed ID: 6267528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.